Dupont Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,907
| Closed | -$373K | – | 1649 |
|
|
2020
Q4 | $373K | Sell |
23,907
-6,248
| -21% | -$97.5K | 0.01% | 958 |
|
|
2020
Q3 | $285K | Sell |
30,155
-2,020
| -6% | -$19.1K | 0.01% | 992 |
|
|
2020
Q2 | $288K | Sell |
32,175
-14,284
| -31% | -$128K | 0.01% | 984 |
|
|
2020
Q1 | $296K | Hold |
46,459
| – | – | 0.01% | 866 |
|
|
2019
Q4 | $389K | Buy |
46,459
+14,615
| +46% | +$122K | 0.01% | 958 |
|
|
2019
Q3 | $288K | Buy |
+31,844
| New | +$288K | 0.01% | 1016 |
|
|
2018
Q2 | – | Sell |
-13,583
| Closed | -$258K | – | 1030 |
|
|
2018
Q1 | $258K | Buy |
+13,583
| New | +$258K | 0.01% | 785 |
|